Knight Net Income Applicable To Common Shares from 2010 to 2026
| GUD Stock | CAD 5.98 0.07 1.18% |
Net Income Applicable To Common Shares | First Reported 2010-12-31 | Previous Quarter 5 M | Current Value 5.2 M | Quarterly Volatility 13.7 M |
Check Knight Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Knight Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 64.1 M, Interest Expense of 9.2 M or Selling General Administrative of 26.3 M, as well as many indicators such as Price To Sales Ratio of 1.59, Dividend Yield of 0.31 or PTB Ratio of 1.11. Knight financial statements analysis is a perfect complement when working with Knight Therapeutics Valuation or Volatility modules.
Knight | Net Income Applicable To Common Shares |
Latest Knight Therapeutics' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Knight Therapeutics over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Knight Therapeutics' Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Knight Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Knight Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (22,993,312) | |
| Geometric Mean | 20,952,695 | |
| Coefficient Of Variation | (59.38) | |
| Mean Deviation | 10,550,934 | |
| Median | (29,892,000) | |
| Standard Deviation | 13,653,078 | |
| Sample Variance | 186.4T | |
| Range | 35.1M | |
| R-Value | 0.72 | |
| Mean Square Error | 95.4T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 1,950,315 | |
| Total Sum of Squares | 2982.5T |
Knight Net Income Applicable To Common Shares History
About Knight Therapeutics Financial Statements
Knight Therapeutics investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Knight Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 5 M | 5.2 M |
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.